These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17457109)

  • 1. 'Forced treatment interruptions' and risk of HIV resistance in countries adopting law enforcement against marginalized populations.
    Carrieri MP; Spire B
    AIDS; 2007 May; 21(8):1062-3. PubMed ID: 17457109
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment interruptions in the salvage setting: what have we learned?
    Miller V
    Res Initiat Treat Action; 2003; 9(2):17-9. PubMed ID: 14989202
    [No Abstract]   [Full Text] [Related]  

  • 3. Deadly risk of drug-resistant HIV.
    Gulland A
    Nurs Times; 2000 Dec 7-13; 96(49):6. PubMed ID: 11965965
    [No Abstract]   [Full Text] [Related]  

  • 4. "Drug holidays" provide no benefits in HIV treatment.
    Public Health Rep; 2004; 119(1):97. PubMed ID: 15174493
    [No Abstract]   [Full Text] [Related]  

  • 5. Prisons. HIV-positive inmates in danger of treatment resistance.
    AIDS Policy Law; 2005 Jul; 20(14):8. PubMed ID: 16108126
    [No Abstract]   [Full Text] [Related]  

  • 6. Adherence strategies. Monitoring of treatment can help ART resistance. Sustained treatment interruption is worst.
    AIDS Alert; 2008 Oct; 23(10):113-4. PubMed ID: 18935683
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions.
    Eron JJ
    J Infect Dis; 2008 May; 197 Suppl 3():S261-71. PubMed ID: 18447612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV clinic gets ART to toughest cases. Patients with 10-plus meds targeted.
    AIDS Alert; 2010 May; 25(5):51-3. PubMed ID: 20564810
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
    Izopet J; Marchou B; Charreau I; Sauné K; Tangre P; Molina JM; Aboulker JP;
    Antivir Ther; 2008; 13(4):537-45. PubMed ID: 18672532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rand Corp. study seeks participants.
    Wagner G
    Posit Living; 2001 Jan; 10(1):15. PubMed ID: 11548483
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral resistance in the developing world.
    Pillay D
    J HIV Ther; 2007 Dec; 12(4):95-6. PubMed ID: 18578091
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare D has big impact on HIV treatment interruptions. Decreased access to meds, six-fold increase in interruptions.
    AIDS Alert; 2008 Nov; 23(11):121-3. PubMed ID: 19043865
    [No Abstract]   [Full Text] [Related]  

  • 15. New insights into HIV resistance testing: nursing guidelines and implications.
    Kirton CA; Kurtyka D; Sterken DJ
    J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning for interruptions in service: expecting the unexpected.
    Valenti WM
    AIDS Read; 2005 Nov; 15(11):585-8. PubMed ID: 16329180
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV epidemics, HIV therapeutics: recent trends.
    Laurence J
    AIDS Read; 2003 Sep; 13(9):407-8. PubMed ID: 14598784
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-HIV agents. Treatments for drug-resistant HIV coming.
    TreatmentUpdate; 2007; 19(5):1-2. PubMed ID: 17955612
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral drug resistance in HIV-infected children: implications for long-term treatment.
    Tudor-Williams G; Green H
    J HIV Ther; 2007 Dec; 12(4):99-100. PubMed ID: 18578093
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of antiretroviral resistance and impact on treatment outcomes.
    Cane P
    J HIV Ther; 2007 Dec; 12(4):82-4. PubMed ID: 18391892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.